Gilles Montalescot is Professor of Cardiology at the Pitié Salpêtrière Hospital in Paris, France, where he heads the Department of Cardiology at the Institute of Cardiology. He is a practicing Interventional Cardiologist and has extensive experience in basic and clinical research. He has been the director of the INSERM research Unit UMRS_1166 on Thrombosis for 10 years. Dr Montalescot has been an investigator for many of the new drugs developed in the past twenty years as well as for many of the new interventional technologies. Dr. Montalescot is a senior scientist and has been the lead investigator of many national or international randomized trials including ADMIRAL, ARMADA, ALBION, STEEPLE, ARCHIPELAGO, ABOARD, ACAPULCO, ATOLL, ARCTIC, ANTARCTIC, ACCOAST, ATLANTIC, AEGEAN, AMERICA, ALBATROS, and the ongoing ATLANTIS, ALPHEUS, ARAMIS, ADRIFT trials. Dr Montalescot is the Chairman of the ACTION study group, an Academic Research Organization based at Pitié Salpêtrière Hospital in Paris. He has served on several task force committees on antithrombotic drugs and acute coronary syndromes and is the current Chairman of the Stable Coronary Artery disease guidelines of the European Society of Cardiology. Dr Montalescot has received several awards in his country including the J. Valade Prize from the Fondation de France and the J.Escalle award from the National Academy of Medicine. He is a member of several editorial boards and has published over 600 peer reviewed original articles in journals such as the NEJM, JAMA, Lancet. Internationally, Dr. Montalescot has also been an invited speaker at plenary sessions of major congresses such as the European Society of Cardiology, the American College of Cardiology ,and the American Heart Association.

Peter Grant is Professor of Medicine and a diabetologist with a particular interest in the management of vascular risk in patients with diabetes. His research focuses on understanding the molecular basis of the strong biological link between diabetes and cardiovascular (CV) disease, in particular, the genetic and environmental determinants of thrombotic risk in relation to insulin resistance and CV disease. He has published around 240 original research articles in peer-reviewed journals with an H-index of 70. 

Professor Grant is founder and Editor-in-Chief of the international journal, Diabetes and Vascular Disease Research, a peer reviewed journal that publishes research linking these two conditions. Professor Grant was joint chair of the ESC/EASD guidelines committee (2010-13), (2017-20) on cardiovascular disease prevention and management in diabetes published in the European Heart Journal. He is a Fellow of the Academy of Medical Sciences.